Immunomodulatory Effects of Drugs for Treatment of Immune-Related Diseases

More than 90% of diseases possess immunological abnormalities. Disorders such as inflammation, hypersensitivity, autoimmunity and immunodeficiency are simple examples of how the immune system misinterprets its surroundings and goes awry. Multiple sclerosis, rheumatoid arthritis, systemic lupus eryth...

Full description

Saved in:
Bibliographic Details
Superior document:Frontiers Research Topics
:
Year of Publication:2017
Language:English
Series:Frontiers Research Topics
Physical Description:1 electronic resource (108 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993543529204498
ctrlnum (CKB)4100000002484669
(oapen)https://directory.doabooks.org/handle/20.500.12854/49990
(EXLCZ)994100000002484669
collection bib_alma
record_format marc
spelling Azzam A. Maghazachi auth
Immunomodulatory Effects of Drugs for Treatment of Immune-Related Diseases
Frontiers Media SA 2017
1 electronic resource (108 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Frontiers Research Topics
More than 90% of diseases possess immunological abnormalities. Disorders such as inflammation, hypersensitivity, autoimmunity and immunodeficiency are simple examples of how the immune system misinterprets its surroundings and goes awry. Multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel diseases, among many others are manifestations of immune cells attacking normal tissues. On the other hand, damping the immune system leads to diseases such as cancer, AIDS, and severe combined immunodeficiency. The last ten years witnessed an explosion in developing drugs that target the immune system. Several novel monoclonal antibodies have been approved for treatment of various diseases confirming that personalized medicine approach is robust in combating diseases. Hence, the future holds great promise for using personalized and targeted medicine rather than generalized medications that, in most circumstances, proven to be ineffective and characteristically exert side effects. Approaches such as generating novel adjuvants that can stimulate the immune system without harmful side effects, targeting inflammatory cytokines and chemokines, harnessing and activating innate immune cells such as natural killer cells or dendritic cells, are examples of future approaches to treat autoimmune diseases, AIDS, and various forms of cancer resulting from chronic inflammation. More recently, targeting immune checkpoint molecules have shown therapeutic response against lung cancer and melanoma. Identifying molecules involved in autophagy is another example of how personalized medicine might help treat patients with refractory asthma and autoimmune diseases. This topic introduces the reader to these novel approaches of manipulating the immune system and developing targeted therapeutic strategies for treatment of various diseases.
English
Drugs
Multiple sclerosis
NK cells
Leukemia
AIDS
Adjuvants
Lymphoma
Autophagy
Chemokines
Cancer
2-88945-288-3
language English
format eBook
author Azzam A. Maghazachi
spellingShingle Azzam A. Maghazachi
Immunomodulatory Effects of Drugs for Treatment of Immune-Related Diseases
Frontiers Research Topics
author_facet Azzam A. Maghazachi
author_variant a a m aam
author_sort Azzam A. Maghazachi
title Immunomodulatory Effects of Drugs for Treatment of Immune-Related Diseases
title_full Immunomodulatory Effects of Drugs for Treatment of Immune-Related Diseases
title_fullStr Immunomodulatory Effects of Drugs for Treatment of Immune-Related Diseases
title_full_unstemmed Immunomodulatory Effects of Drugs for Treatment of Immune-Related Diseases
title_auth Immunomodulatory Effects of Drugs for Treatment of Immune-Related Diseases
title_new Immunomodulatory Effects of Drugs for Treatment of Immune-Related Diseases
title_sort immunomodulatory effects of drugs for treatment of immune-related diseases
series Frontiers Research Topics
series2 Frontiers Research Topics
publisher Frontiers Media SA
publishDate 2017
physical 1 electronic resource (108 p.)
isbn 2-88945-288-3
illustrated Not Illustrated
work_keys_str_mv AT azzamamaghazachi immunomodulatoryeffectsofdrugsfortreatmentofimmunerelateddiseases
status_str n
ids_txt_mv (CKB)4100000002484669
(oapen)https://directory.doabooks.org/handle/20.500.12854/49990
(EXLCZ)994100000002484669
carrierType_str_mv cr
hierarchy_parent_title Frontiers Research Topics
is_hierarchy_title Immunomodulatory Effects of Drugs for Treatment of Immune-Related Diseases
container_title Frontiers Research Topics
_version_ 1796652030376280067
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02939nam-a2200385z--4500</leader><controlfield tag="001">993543529204498</controlfield><controlfield tag="005">20231214133241.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2017 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000002484669</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/49990</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000002484669</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Azzam A. Maghazachi</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Immunomodulatory Effects of Drugs for Treatment of Immune-Related Diseases</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Frontiers Media SA</subfield><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (108 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Frontiers Research Topics</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">More than 90% of diseases possess immunological abnormalities. Disorders such as inflammation, hypersensitivity, autoimmunity and immunodeficiency are simple examples of how the immune system misinterprets its surroundings and goes awry. Multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel diseases, among many others are manifestations of immune cells attacking normal tissues. On the other hand, damping the immune system leads to diseases such as cancer, AIDS, and severe combined immunodeficiency. The last ten years witnessed an explosion in developing drugs that target the immune system. Several novel monoclonal antibodies have been approved for treatment of various diseases confirming that personalized medicine approach is robust in combating diseases. Hence, the future holds great promise for using personalized and targeted medicine rather than generalized medications that, in most circumstances, proven to be ineffective and characteristically exert side effects. Approaches such as generating novel adjuvants that can stimulate the immune system without harmful side effects, targeting inflammatory cytokines and chemokines, harnessing and activating innate immune cells such as natural killer cells or dendritic cells, are examples of future approaches to treat autoimmune diseases, AIDS, and various forms of cancer resulting from chronic inflammation. More recently, targeting immune checkpoint molecules have shown therapeutic response against lung cancer and melanoma. Identifying molecules involved in autophagy is another example of how personalized medicine might help treat patients with refractory asthma and autoimmune diseases. This topic introduces the reader to these novel approaches of manipulating the immune system and developing targeted therapeutic strategies for treatment of various diseases.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Drugs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Multiple sclerosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NK cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Leukemia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">AIDS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Adjuvants</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Lymphoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Autophagy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Chemokines</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Cancer</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">2-88945-288-3</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:47:53 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2018-03-10 17:16:05 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5337391400004498&amp;Force_direct=true</subfield><subfield code="Z">5337391400004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337391400004498</subfield></datafield></record></collection>